Company Filing History:

11 out of 4,942

Hoffmann-la Roche Inc.

patents

1 out of 1

Basilea Parmaceutica Ag

patent

1 out of 68

Basilea Pharmaceutica Ag

patents

Years Active: 1984-2004

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6740642 - Macrolides with antibacterial activity (2004-05-25),

2. 6583133 - Propenyl cephalosporin derivatives and process for the manufacture thereof (2003-06-24),

3. 6294668 - Vinylpyrrolidinone cephalosporin derivatives (2001-09-25),

4. 6150350 - Antimicrobial compositions (2000-11-21),

5. 5981519 - Vinyl-pyrrolidinone cephalosporins (1999-11-09),

6. 5939410 - 1-carba-(dethia)-cephalosporin derivatives (1999-08-17),

7. 5935950 - Cephalosporin pyridinium derivatives (1999-08-10),

8. 5776895 - Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic (1998-07-07),

9. 5750503 - Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic (1998-05-12),

10. 5523400 - Cephalosporin antibiotics (1996-06-04),

11. 5438052 - Cephalosporin derivatives (1995-08-01),

12. 4689227 - Antibacterial composition (1987-08-25),

13. 4431804 - Thiazolylacetamido compounds (1984-02-14),

Title: The Innovative Journey of Inventor Peter Angehrn

Introduction: Peter Angehrn, a prolific inventor based in Bockten, Switzerland, has made significant contributions to the field of pharmaceuticals with his remarkable ingenuity. With a total of 13 patents to his name, Angehrn's inventive spirit is truly inspiring.

Latest Patents: Among his latest patents are "Macrolides with antibacterial activity" and "Propenyl cephalosporin derivatives and process for the manufacture thereof," showcasing his expertise in developing novel pharmaceutical compounds that address critical medical needs.

Career Highlights: With a notable career path, Peter Angehrn has lent his innovative talents to renowned companies such as Roche (formerly known as Hoffmann-La Roche Inc.). During his tenure, Angehrn has consistently pushed the boundaries of pharmaceutical research, resulting in groundbreaking inventions that have the potential to improve healthcare outcomes globally.

Collaborations: Collaboration plays a crucial role in the world of innovation, and Peter Angehrn has had the pleasure of working alongside esteemed colleagues such as Ingrid Heinze-Krauss and Malcolm Page. Together, they have fueled each other's creativity and brought forth inventive solutions to complex challenges in the pharmaceutical industry.

Conclusion: Peter Angehrn's journey as an inventor is a testament to the power of perseverance, creativity, and collaboration in driving impactful innovations. His impressive portfolio of patents and successful career trajectory underscore his unwavering commitment to advancing science and improving lives through his pioneering inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.